Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 36.4 1.62%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Supernus Pharmaceuticals EBITDA per Share 2011-2024 | SUPN

Annual EBITDA per Share Supernus Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.45 2.23 3.65 2.96 2.91 2.12 1.14 0.391 0.595 -1.92 -2.37 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.65 -2.37 1.29

Quarterly EBITDA per Share Supernus Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
0.75 0.42 0.32 - 0.16 -0.31 0.47 - -0.01 0.23 0.44 - 0.99 0.89 0.37 - 1.31 0.96 0.59 0.78 0.85 0.88 0.52 0.76 0.82 0.76 0.64 0.67 0.56 0.56 0.35 0.33 0.44 0.26 0.14 - 0.12 0.09 0.1 - - 0.1 -0.32 - -0.54 -0.49 -0.57 - -0.48 -0.52 -4.57 - -5.81 -5 -5.64

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.31 -5.81 -0.147